Antabio
Founded 2009 · $40.5M raised
- Founded
- 2009
- Business Model
- B2B
- Website
- antabio.com
- Total Funding
- $40.5M
- Last Round
- $27.0M Series BDec 2023
- Rounds
- 3
About
Novel combination treatment against multidrug-resistant pathogens.
Summary
Antabio is a Biotech company, founded in 2009. It has raised $40.5M in total across 3 rounds, most recently a $27.0M Series B round in Dec 2023. Investors include AMR Action Fund, IXO Private Equity and European Innovation Council Fund.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company